DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Lasa Supergenerics Limited — Integrated Filing- Financial

NSE 2 hrs ago·14 Aug 2026, 1:30 pm

Lasa Supergenerics

Lasa Supergenerics Limited has submitted its integrated filing for the quarter ended June 30, 2026. This document provides a comprehensive view of the company's financial performance over the specified period.

For investors, this filing is a key update that offers transparency into the company's current operational status and financial health. It allows stakeholders to assess the company's trajectory and make informed decisions based on the disclosed information.

Investors should review the filing for insights into the company's strategy and performance metrics. Keeping an eye on future updates from the company will be important to understand its long-term outlook.